Affiliate disclosure: Digital Adsvertic is an independent publisher. We may receive compensation if you use an affiliate link on this page. Check the advertiser’s current terms before taking action.
Shed, formerly promoted as ShedRx, is a US telehealth clinic offering prescription weight-management programs. Its listed injection options include compounded semaglutide, compounded tirzepatide and the FDA-approved brand-name medications Wegovy and Zepbound. Patients generally complete an online health form, undergo review by a licensed provider and, if approved, receive medication through home delivery.
The service may appeal to adults who want to explore medical weight management without arranging every appointment through a local office. However, filling out the advertised five-minute form does not guarantee eligibility, a prescription or immediate treatment. A live visit may be required in some states or clinical situations, and available medications can vary by location.
This guide explains what Shed offers, how its online process works, what published starting prices mean and why consumers should distinguish compounded injections from FDA-approved products before enrolling.
How the Shed Weight-Management Program Works
Shed combines a digital intake, clinician review, prescription services when medically appropriate and ongoing support in one online program. The core experience is designed to take place from home, although state telehealth rules and an individual provider’s judgment may affect the exact process.
Shed is not an over-the-counter supplement store. Its weight-management injections require a prescription. A licensed provider must assess whether treatment is appropriate based on the information supplied, the patient’s health history and any additional consultation that is required.
What Shed Actually Offers
Shed lists weekly semaglutide and tirzepatide injections as part of its weight-management lineup. Depending on availability and eligibility, the offered product may be a compounded medication or an FDA-approved brand.
- Compounded semaglutide: A pharmacy-prepared medication containing semaglutide. The compounded product itself is not FDA-approved.
- Compounded tirzepatide: A pharmacy-prepared tirzepatide product that is also not FDA-approved.
- Wegovy: An FDA-approved brand-name semaglutide medication prescribed for eligible patients under its approved labeling.
- Zepbound: An FDA-approved brand-name tirzepatide medication prescribed for eligible patients under its approved labeling.
These options should not be treated as interchangeable merely because they can involve the same active ingredient. FDA-approved drugs undergo agency review for safety, effectiveness and manufacturing quality before approval. Compounded drugs do not go through that premarket review.
Potential Benefits of an Online Program
The practical advantage of Shed is convenience rather than guaranteed results. The intake, payment and much of the follow-up can be handled online, while prescribed medication is shipped to the patient. That can reduce the need to coordinate separate clinic and pharmacy visits.
Features that may be useful for an eligible patient include:
- An online health questionnaire that Shed describes as taking about five minutes to complete.
- Review by a licensed medical provider rather than automatic access to medication.
- Home delivery after approval, prescribing and pharmacy processing.
- Access to follow-up services within the program.
- Multiple prescription pathways, including compounded and FDA-approved options.
- The ability to use an eligible HSA or FSA card for qualifying treatment or services, subject to plan rules.
The five-minute description applies only to the initial form. It should not be read as a promise that a patient will be approved, receive a prescription or begin treatment within five minutes.
What Semaglutide and Tirzepatide Do
Semaglutide and tirzepatide act on hormone pathways involved in appetite and blood-sugar regulation. They may help an eligible patient feel satisfied with less food or remain full for longer, but an individual response cannot be predicted. Some patients lose substantial weight, some experience a smaller change and others stop treatment because of side effects or limited benefit.
Tirzepatide acts on both GIP and GLP-1 receptors, while semaglutide acts on GLP-1 receptors. That distinction does not establish which option is best for a particular person. Medical history, contraindications, availability, tolerability, treatment goals and cost all matter. A prescriber should make the medication recommendation after reviewing the patient’s circumstances.
No injection establishes permanent weight loss. Continued results may depend on ongoing treatment and sustainable nutrition, activity and behavioral changes. Weight regain can occur after medication is discontinued, so consumers should be cautious about advertising language suggesting they will lose weight “for the last time.”
How to Get Started With Shed
Complete the Online Health Form
The first step is an online questionnaire covering information relevant to prescribing. Applicants should answer completely and accurately, even when a detail seems unrelated to weight. Omitting a diagnosis, medication or prior reaction can interfere with a provider’s ability to assess risk.
Information commonly relevant to a medical weight-management review includes current medications, allergies, previous weight-loss treatment, pregnancy status and personal or family medical history. The provider may request clarification, documentation or a live consultation before reaching a decision.
Wait for the Clinical Review
A licensed provider evaluates the submission and decides whether prescription treatment is medically appropriate. Approval is not automatic, and selecting or paying for a preferred option does not require the clinician to prescribe it. The provider may recommend another treatment, request an appointment or determine that the program is unsuitable.
Telehealth requirements differ among states. Shed notes that some patients may need a live visit depending on their location and treatment. Consumers should therefore confirm that the service and desired medication are available in their state before assuming the entire process will be questionnaire-based.
Review the Prescription and Program Details
If approved, read the treatment instructions before medication ships. Confirm the drug name, whether it is compounded or FDA-approved, the prescribed dose, dosing schedule, pharmacy, storage requirements and instructions for missed doses. Ask questions if the delivered label does not match what was discussed.
This review is especially important for compounded injections because concentrations and delivery devices can differ. Do not calculate a dose from social media advice or reuse instructions supplied with another product. The FDA has received reports of dosing errors involving compounded semaglutide, including errors linked to patients measuring incorrect amounts. Its GLP-1 safety guidance discusses these concerns and reported adverse events.
Arrange Delivery and Follow-Up
Medication is shipped after the clinical and pharmacy steps are completed. Delivery timing is not the same as intake time and can be affected by prescription processing, supply, state restrictions or the need for more information.
Once treatment begins, follow the prescribed schedule and complete required check-ins. Report side effects and changes in health rather than adjusting the dose independently. If Shed offers promotional pricing, a commitment plan or a results-related guarantee, save the applicable terms displayed when enrolling. Such offers can carry adherence, eligibility and check-in conditions.
Shed Pricing, Payment and Plan Terms
Published Starting Prices
At the research date, Shed displayed compounded semaglutide plans starting at $159 per month. Compounded tirzepatide was displayed from $239 per month when purchased with a 12-month plan. A shorter commitment could cost more per month.
“Starting at” is important. The final cost can depend on the medication, dose, plan length and current offer. It may also change over time. Before authorizing payment, examine:
- The exact medication and quantity included.
- Whether the displayed rate requires a long-term commitment.
- The total amount charged and the billing frequency.
- Whether clinician review, supplies and shipping are included.
- Renewal, pause, cancellation and refund provisions.
- What happens financially if a provider does not approve treatment.
- Whether higher doses or medication changes affect the price.
Brand-name Wegovy and Zepbound should not be assumed to cost the same as the displayed compounded-drug plans. Coverage and out-of-pocket expenses can differ by product, pharmacy benefit and insurance policy.
HSA and FSA Payments
Shed states that eligible HSA or FSA cards may be used for qualifying treatments and services. That does not mean every purchase is automatically a qualified medical expense under every plan. Administrators can require documentation, and an expense that is declined or later found ineligible may become the consumer’s responsibility.
Before using tax-advantaged funds, check the current rules with the HSA or FSA administrator. Keep itemized receipts and any requested medical documentation. Card acceptance at checkout is a payment function, not a final determination of tax eligibility or reimbursement.
Insurance and Affordability
Do not assume an advertised cash price will be submitted to insurance. Ask whether the selected plan is self-pay, whether insurance is used for any part of the service and whether prior authorization support is included for a brand-name prescription.
A useful comparison should consider the complete expected expense rather than one introductory monthly figure. Include consultation or membership fees, medication, supplies, shipping and the cost of follow-up. Also consider the financial effect of committing for several months if treatment later becomes unsuitable.
Eligibility and Important Medical Limitations
Who May Qualify?
Eligibility is determined by a licensed provider, not by an advertisement or online score alone. A person’s age, weight-related health profile, current prescriptions, treatment history and medical risks may all affect the decision. State availability and prescribing law also apply.
Consumers should not borrow another person’s medication, purchase it for someone who was not evaluated or use a prescription obtained under inaccurate information. A legitimate telehealth pathway still requires an individualized clinician-patient relationship and a valid prescription.
Who Should Seek Individual Medical Advice First?
Anyone with a complex medical history should discuss it openly with the reviewing provider and, when appropriate, their regular clinician. This is particularly important for people who are pregnant, planning pregnancy or breastfeeding, as well as those with significant gastrointestinal, pancreatic, gallbladder, kidney or endocrine concerns.
Patients should also disclose diabetes medicines and other drugs that can affect blood sugar or digestion. This guide cannot determine whether semaglutide, tirzepatide or any Shed program is suitable for an individual.
Compounded Injections Require Extra Scrutiny
Compounded Does Not Mean FDA-Approved
Shed expressly identifies its compounded medications as not FDA-approved. The FDA explains that compounded GLP-1 products are not reviewed for safety, effectiveness or quality before they are marketed. The agency generally says compounded drugs should be used when a patient’s medical need cannot be met by an available FDA-approved drug.
This does not mean every compounded prescription is inherently inappropriate. It means the regulatory pathway and assurances differ. Patients should know why a compounded option is being recommended, which pharmacy prepares it and how its formulation and instructions differ from an approved brand.
The legal environment is also changing. In its GLP-1 compounding policy update, the FDA stated on April 1, 2026, that semaglutide and tirzepatide were not on its drug-shortage list or the 503B bulks list. Those circumstances materially restrict when copies may qualify for federal compounding exemptions. Availability can therefore change independently of a telehealth company’s advertised lineup.
Marketing Claims Deserve Careful Reading
Consumers may encounter telehealth advertisements that place a compounded medication beside a familiar brand or emphasize an active ingredient without clearly explaining regulatory status. The FDA announced warning letters to 30 telehealth companies concerning misleading compounded-GLP-1 promotion, including representations that could imply compounded products were the same as approved drugs. The announcement does not itself state that Shed received a warning letter, but the broader FDA telehealth marketing warning illustrates why precise product identification matters.
Before paying, obtain clear answers to three questions: Is the product FDA-approved or compounded? Who manufactures or compounds it? What exact medication and concentration will appear on the prescription label?
Side Effects and Urgent Concerns
Semaglutide and tirzepatide can cause gastrointestinal side effects such as nausea, vomiting, diarrhea, constipation and abdominal discomfort. More serious problems can occur. The appropriate response depends on the symptom, severity, medical history and prescribed product.
Patients should read the medication information, follow provider instructions and know how to contact the care team. Severe or persistent symptoms, signs of dehydration, an allergic reaction or another urgent concern require prompt medical attention. In an emergency, use emergency services rather than waiting for a routine telehealth message response.
Is Shed a Practical Choice?
Shed may be worth considering for an adult who values online intake, home delivery and access to clinician-reviewed weight-management options. Its range of compounded and FDA-approved injections gives eligible patients more than one pathway to discuss.
The service is less straightforward for someone who assumes every option is FDA-approved, expects guaranteed approval or wants a month-to-month price while relying on the lowest advertised annual-plan rate. It may also be unsuitable for a person who needs close in-person monitoring or whose medical circumstances require care outside the program’s scope.
Before enrolling, compare the complete cost, commitment period, medication category, pharmacy information and follow-up arrangements. The strongest decision is based on the actual prescription and current terms—not a broad promise of fast or permanent weight loss.
Frequently Asked Questions About Shed
Are ShedRx and Shed the Same Service?
The ShedRx web domain redirects to Shed’s current website, and the program is now branded as Shed. Consumers searching for ShedRx weight-loss injections are generally looking for the current Shed telehealth service. Check the domain and checkout details carefully to avoid similarly named third-party websites.
Can I Start Shed Treatment in Five Minutes?
No such treatment-start guarantee is established. Shed describes its health form as taking approximately five minutes. Provider review, a possible live visit, prescribing, payment, pharmacy processing and delivery happen afterward. Some applicants will not qualify, and others may need to supply more information.
Does Shed Guarantee Weight Loss?
No medication produces guaranteed or permanent weight loss for every patient. Results and tolerability vary. Any separate promotional guarantee should be read independently because it may require medical eligibility, adherence, regular check-ins and compliance with other terms. Save a copy of the conditions that apply when purchasing.
Are Shed’s Injections FDA-Approved?
It depends on the product. Wegovy and Zepbound are FDA-approved brand-name drugs. Shed’s compounded semaglutide and compounded tirzepatide are not FDA-approved. Compounded products are not reviewed by the FDA for safety, effectiveness or manufacturing quality before marketing, even when they contain an ingredient also found in an approved drug.
Will Shed Ship Medication Anywhere in the United States?
Availability varies by state, medication and applicable law. A live appointment may also be required in certain locations or circumstances. Confirm current state availability during intake rather than assuming nationwide advertising means every treatment can be shipped to every state.
Can I Use an HSA or FSA Card?
Shed says eligible HSA and FSA cards can be used for qualifying treatments and services. Eligibility depends on the expense and the consumer’s plan. Ask the plan administrator about documentation and reimbursement rules; successful card processing does not by itself prove that an expense is tax-qualified.
How Much Does Shed Cost?
Published starting prices reviewed for this guide were $159 per month for compounded semaglutide and $239 per month for compounded tirzepatide with a 12-month plan. Shorter commitments cost more, and prices can change. Confirm the total charge, included services, renewal rules and dose-related costs at checkout.
Should I Choose Semaglutide or Tirzepatide?
That decision should be made with a licensed provider. The drugs act differently, and suitability can depend on medical history, contraindications, other medications, previous treatment, side effects, availability and cost. An online advertisement cannot determine which option is safer or more appropriate for an individual.
What Should I Verify Before My First Dose?
Check the patient name, medication, concentration, prescribed amount, schedule, storage instructions, expiration information and dispensing pharmacy. Make sure you understand how to use the supplied device or syringe. If anything differs from the provider’s instructions, contact the program or dispensing pharmacy before injecting the medication.
Leave a Reply